PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride
- Product NDC
- 10572-400
- 11-digit product format
- 105720400
- Labeler code
- 10572
- Product ID
- 10572-400_16fd321d-f891-4083-99f7-26e2e122619c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride
- Dosage form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Labeler
- Affordable Pharmaceuticals, LLC
- Application
- NDA019797
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2013-02-08
- Marketing end
- 0000-00-00
- Substance
- POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE
- Active strength
- 420 g/4L; g/4L; g/4L; g/4L
- Pharmacologic classes
- Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record